Wachovia upgrades ResMed (NYSE: RMD) to Outperform.

Wachovia analyst says, "Our upgrade is based on the following: (1) RMD's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE